Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion type Assertion NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_head.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion evidence source_evidence_literature NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion SIO_000772 23256743 NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion wasDerivedFrom befree-20140225 NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.
- NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_assertion wasGeneratedBy ECO_0000203 NP756536.RAa3LFLQZuPxEtHcTTQ6cxPphM6W3OLWERLkfAA-r_TX4130_provenance.